about
Intravenous lacosamide in clinical practice-Results from an independent registry.Lacosamide in status epilepticus: Systematic review of current evidence.First report of a Chinese strain of coxsackie B3 virus infection in a newborn in Germany in 2011: a case report.Fast evaluation of interictal spikes in long-term EEG by hyper-clustering.Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians.Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies.Dihydropyrimidinase deficiency: Phenotype, genotype and structural consequences in 17 patients.18F-FDG PET in a 10-year-old female patient with subacute sclerosing panencephalitis.Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins.Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets.Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence.Frontal Lobe Epilepsy Surgery in Childhood and Adolescence: Predictors of Long-Term Seizure Freedom, Overall Cognitive and Adaptive Functioning.Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.Intelligence quotient improves after antiepileptic drug withdrawal following pediatric epilepsy surgery.Efficacy and tolerability of methylprednisolone pulse therapy in childhood epilepsies other than infantile spasms.Epileptic phenotypes, electroclinical features and clinical characteristics in 17 children with anti-NMDAR encephalitis.Sodium channel blockers in KCNQ2-encephalopathy: Lacosamide as a new treatment option.Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From GermanyInvasive EEG-electrodes in presurgical evaluation of epilepsies: Systematic analysis of implantation-, video-EEG-monitoring- and explantation-related complications, and review of literatureThe role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: Current evidence and future perspectives3p25.3 microdeletion of GABA transportersSLC6A1andSLC6A11results in intellectual disability, epilepsy and stereotypic behaviorPostmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescentsAttention and executive functions in the early course of pediatric epilepsyFrom theory to practice: Critical points in the 2017 ILAE classification of epileptic seizures and epilepsiesIntranasal midazolam as first-line inhospital treatment for status epilepticus: a pharmaco-EEG cohort studyCounseling and social work for people with epilepsy in Germany: A cross-sectional multicenter study on demand, frequent content, patient satisfaction, and burden-of-diseaseFirst clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre studyA multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany
P50
Q30314982-5E3294B6-8EBF-4AB1-A1F9-2C2D9CFAB90DQ30399934-1554ECE0-ACFA-4312-9BD6-E3D6E556C8A7Q33776807-B6A0D166-0981-411F-B733-7FB877762698Q38009391-98BDAF90-807C-4A43-ADD6-A62715C09BD9Q38743191-3674DD33-4005-4822-A426-8A92B0927024Q39493334-4DD2D367-6412-4156-B141-2AA861379A0CQ43110714-0C843F0C-FEAC-4060-AB70-6449DFB63B51Q44844906-23D0DE00-7F8B-431B-8504-7958A426AF79Q45383296-F6834257-5DC1-42C2-8822-C6D18EBC5B83Q46684597-4A9A37C6-66E1-4B69-8748-BB7584B85780Q47235722-86BF5746-B987-48F4-9BAB-72E24A8D0711Q47652146-0E14A1F3-BB52-4042-A584-918EAC01E5BEQ47733662-2EB09E82-806B-4003-ACCB-6F6D214F1C75Q47978577-DC0C70F8-6AAA-422A-85DA-48C300A49200Q48032965-EC3807DD-790D-48FA-8661-AE5D4CBA33D1Q50104891-6C8C6536-7032-4B7C-8D84-4C9A8CB3B722Q50206219-980A773F-1297-45DB-B405-ED236730A4C7Q51244210-9E4ACDC8-8CD5-4209-AA46-EBED9DEA4EC2Q57926644-66A6A655-CD0A-411D-AA70-A70939A531A5Q57926665-031650E4-72C4-4297-9122-25A010855525Q57926685-CC69FA66-E53B-404B-B70C-3468FD5BB43DQ58193238-7EB9223B-63E1-4B7C-A811-C884B6D27442Q58583545-835B7BB7-CA00-4415-AE1B-A75F2B6CF90CQ89201206-36EEE78E-F3BE-412F-A8E4-2619CA618532Q89774440-9226B7AD-CF46-4B95-A568-1D55F84C3DD1Q91086335-F1EB9737-E561-4B9E-BB8D-F5BF636976FFQ91092347-FB30AA80-F273-483D-9A76-7B1FD49B7055Q91129313-641A0E9C-3D3C-4013-864B-CDDB807D14EAQ93076237-215EA888-917D-4339-8C51-04F39AD9CE23
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1545-7364
@en
name
Susanne Schubert-Bast
@ast
Susanne Schubert-Bast
@en
Susanne Schubert-Bast
@es
Susanne Schubert-Bast
@nl
type
label
Susanne Schubert-Bast
@ast
Susanne Schubert-Bast
@en
Susanne Schubert-Bast
@es
Susanne Schubert-Bast
@nl
prefLabel
Susanne Schubert-Bast
@ast
Susanne Schubert-Bast
@en
Susanne Schubert-Bast
@es
Susanne Schubert-Bast
@nl
P214
P106
P1153
55509028600
P214
P31
P496
0000-0003-1545-7364
P7859
viaf-69865595